Yahoo Web Search

Search results

    • Poolbeg Pharma confirms US patent grant

      Poolbeg Pharma confirms US patent grant

      Proactive Investors· 5 days ago

      Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) has been granted a full patent in the United States for its drug candidate POLB 001, aimed at treating and...

    • Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023

      Digital Journal· 6 days ago

      ...immunotherapy-induced CRS Independent Advisory Board of Key Opinion Leaders, healthcare payers and clinical trial experts, were supportive of POLB 001's potential to both prevent and treat cancer immunotherapy-induced ...Chairman Jeremy Skillington, PhD, Chief Executive Officer of Poolbeg Pharma,...